U.S. healthcare ranking poor--again

The U.S. health system ranks last of 11 countries ranked in the Commonwealth Report. This marks the fifth time the U.S. made the bottom of the list.

Mirror, Mirror on the Wall: How the Performance of the U.S. Health Care System Compares Internationally, used criteria such as quality, efficiency and access to care to reach its conclusion. The report, however, expects the U.S. to score better next time due to the Affordable Care Act.

The U.K. took first place, spending $3,406 per person, on average, compared with $8,508 in the U.S. That higher spend does not link to better outcomes.

For example, the U.S. ranked last on infant mortality and on potentially preventable deaths with timely access to effective healthcare and second-to-last on healthy life expectancy at 60. More than one-third of U.S. adults said they skipped a recommended test, a treatment or follow-up care because of cost. About 40 percent of U.S. adults who had visited an emergency room could have been treated by a regular doctor, if one had been available, the report said.

Karen Davis, of the Roger C. Lipitz Center for Integrated Health Care at Johns Hopkins Bloomberg School of Public Health, was the lead author of the report which has previously been published in 2004, 2006, 2007 and 2010.

The 10 countries that outranked the U.S., according to the report are: U.K., Switzerland, Sweden, Australia, Germany (tied), The Netherlands (tied), New Zealand (tied), Norway (tied), France (tied) and Canada.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.